Why this broker thinks the Metcash (ASX:MTS) share price is great value

Is this ASX share great value right now?

The Metcash Limited (ASX: MTS) share price was on form on Tuesday and pushed higher.

The wholesales distributor's shares rose just over 2% to $3.68. This means the Metcash share price is now up 28% since this time last year.

Smiling female investor holds hands up in victory in front of a laptop

Image source: Getty Images

Why did the Metcash share price push higher?

As well as getting a lift from a broad market rebound today, the Metcash share price was boosted by a broker note out of Goldman Sachs.

According to the note, the broker has retained its buy rating and $3.95 price target on its shares.

Based on the current Metcash share price, this price target implies potential upside of 7.3% over the next 12 months excluding dividends. Including them, the potential return stretches to approximately 12.5%.

What did the broker say?

Goldman Sachs appears confident that Metcash will deliver a strong full year result for FY 2021 next week.

The broker is forecasting an 8.2% increase in revenue of $14,088 million for the 12 months. Goldman expects this to be driven by a 10.3% rise in Supermarket sales, a 17% jump in Liquor sales, and a 20.5% increase in Hardware sales. However, this will be offset slightly by a 32% decline in Convenience sales following the loss of contracts.

In respect to earnings, its analysts are expecting Metcash's underlying earnings before interest and tax (EBIT) to come in at $432.3 million, which is up 33.3% on the prior corresponding period.

Finally, on the bottom line, an underlying profit after tax of $281.5 million is being forecast by Goldman Sachs. This will be a 34% increase on FY 2020's underlying profit after tax of $209.7 million.

Based on its expectations for FY 2021, the Metcash share price is currently trading at 13x full year earnings. Though, it is worth noting that the company's earnings are forecast to soften in FY 2022 before growing again in FY 2023. This means its shares are actually trading at 15x FY 2022 earnings based on the broker's forecasts.

Still, based on its recommendation, this appears to be a level that the broker thinks is attractive and offers a compelling risk/reward.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

A little girl wearing wonky glasses checks out what's happening in the world on a mobile phone.
Broker Notes

Buy, hold, sell: Paladin Energy, Accent, Sigma Healthcare shares

Experts reveal the reasons behind their new ratings.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Opinions

3 reasons why I think this leading ASX 200 share is a buy

This underrated business could be a top buy today…

Read more »

Man in shirt and tie falls face first down stairs.
Record Lows

I think this ASX 200 stock looks like a bargain after hitting an all-time low: Here's why

The ASX shares fell another 8% on Tuesday.

Read more »

A woman looks excited as she fans out a wad of Aussie $100 notes.
Broker Notes

Macquarie predicts 90% upside and an 8% dividend yield for this ASX share

If the broker is right, this share will pay off nicely.

Read more »

Man working on a laptop from home.
ASX Share Market News

5 things to watch on the ASX 200 on Wednesday

It could be another tough session for Aussie investors on hump day.

Read more »

A woman sprints with a trail of fire blazing from her body.
Opinions

I hunted the ASX for shares with the potential to double. This one stood out

Do you have this ASX share in your investment portfolio?

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Opinions

I wanted growth, not hype. Only 3 ASX shares passed my checks

One of these ASX shares is tipped to climb up to 38%.

Read more »